General Information of Drug (ID: DM3RSQK)

Drug Name
STAT-600 Drug Info
Indication
Disease Entry ICD 11 Status REF
Acute radiation syndrome NF00 Phase 1 [1]
Cross-matching ID
TTD Drug ID
DM3RSQK

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Drug(s) Targeting Toll-like receptor 5 (TLR5)
Drug Name Drug ID Indication ICD 11 Highest Status REF
CBLB-502 DMK4FRU Acute radiation syndrome NF00 Phase 2 [2]
Entolimod DMMJXAR Colorectal cancer 2B91.Z Phase 1 [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Toll-like receptor 5 (TLR5) TTCXP8J TLR5_HUMAN Agonist [1]

References

1 Clinical pipeline report, company report or official report of Statera Biopharma
2 Recombinant TLR5 agonist CBLB502 promotes NK cell-mediated anti-CMV immunity in mice. PLoS One. 2014 May 30;9(5):e96165.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)